{"id":6409,"date":"2017-11-30T08:13:36","date_gmt":"2017-11-30T08:13:36","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/"},"modified":"2017-11-30T08:13:36","modified_gmt":"2017-11-30T08:13:36","slug":"aktieoverlatelse","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/aktieoverlatelse\/","title":{"rendered":"Aktie\u00f6verl\u00e5telse"},"content":{"rendered":"<p><span>Gunnar Nihlen (person i ledande st\u00e4llning i Real Heart) och hans hustru Gun-Britt samt deras gemensamma barn k\u00f6per aktier i Real Heart AB av Frontus AB. N\u00e5gra n\u00e4ra v\u00e4nner k\u00f6per \u00e4ven aktier I Real Heart av Frontus.<\/span><\/p>\n<p><span>Totalt antal aktier som Frontus \u00e4ger f\u00f6re f\u00f6r\u00e4ndringen var 1 177 889 st. (8.45%) och efter f\u00f6r\u00e4ndringen 1\u00a0084 838 st. (7.7%).\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <em>st<\/em><\/span><\/p>\n<p><span>S\u00e5v\u00e4l Gunnar Nihlen som Gun-Britt och deras gemensamma barn \u00f6kar d\u00e4rmed sina privata innehav i\u00a0Real Heart.<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><br \/>Azad Najar, VD<br \/>Tel: +46(0)736-673\u00a0463<br \/>E-post:\u00a0<\/span><a href=\"mailto:azad.najar@realheart.se\" rel=\"nofollow\"><span>azad.najar@realheart.se<\/span><\/a>\u00a0<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><em><span>Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian Real Heart AB utvecklar en hj\u00e4rtpump (TAH) som efterliknar kroppens naturliga cirkulation och som ska kunna anv\u00e4ndas som en \u00f6verg\u00e5ngsl\u00f6sning f\u00f6r patienter som v\u00e4ntar p\u00e5 en hj\u00e4rttransplantation.<\/span><\/em><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/las-som-pdf.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2403823%2F760387.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/las-som-pdf.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2403823%2F760387.pdf&type=jpg\"><\/span>L\u00e4s som pdf<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Gunnar Nihlen (person i ledande st\u00e4llning i Real Heart) och hans hustru Gun-Britt samt deras gemensamma barn k\u00f6per aktier i Real Heart AB av Frontus AB. N\u00e5gra n\u00e4ra v\u00e4nner k\u00f6per \u00e4ven aktier I Real Heart av Frontus. Totalt antal aktier som Frontus \u00e4ger f\u00f6re f\u00f6r\u00e4ndringen var 1 177 889 st. (8.45%) och efter f\u00f6r\u00e4ndringen 1\u00a0084&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6409","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn-ci-insider","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aktie\u00f6verl\u00e5telse - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aktie\u00f6verl\u00e5telse - Realheart\" \/>\n<meta property=\"og:description\" content=\"Gunnar Nihlen (person i ledande st\u00e4llning i Real Heart) och hans hustru Gun-Britt samt deras gemensamma barn k\u00f6per aktier i Real Heart AB av Frontus AB. N\u00e5gra n\u00e4ra v\u00e4nner k\u00f6per \u00e4ven aktier I Real Heart av Frontus. Totalt antal aktier som Frontus \u00e4ger f\u00f6re f\u00f6r\u00e4ndringen var 1 177 889 st. (8.45%) och efter f\u00f6r\u00e4ndringen 1\u00a0084...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/aktieoverlatelse\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/aktieoverlatelse\\\/\",\"name\":\"Aktie\u00f6verl\u00e5telse - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2017-11-30T08:13:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/aktieoverlatelse\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/aktieoverlatelse\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/aktieoverlatelse\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aktie\u00f6verl\u00e5telse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aktie\u00f6verl\u00e5telse - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/","og_locale":"sv_SE","og_type":"article","og_title":"Aktie\u00f6verl\u00e5telse - Realheart","og_description":"Gunnar Nihlen (person i ledande st\u00e4llning i Real Heart) och hans hustru Gun-Britt samt deras gemensamma barn k\u00f6per aktier i Real Heart AB av Frontus AB. N\u00e5gra n\u00e4ra v\u00e4nner k\u00f6per \u00e4ven aktier I Real Heart av Frontus. Totalt antal aktier som Frontus \u00e4ger f\u00f6re f\u00f6r\u00e4ndringen var 1 177 889 st. (8.45%) och efter f\u00f6r\u00e4ndringen 1\u00a0084...","og_url":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/","url":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/","name":"Aktie\u00f6verl\u00e5telse - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2017-11-30T08:13:36+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/aktieoverlatelse\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"Aktie\u00f6verl\u00e5telse"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}